Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lifestyle overhaul may ease chest pain in hidden heart disease

NCT ID NCT06025994

Disease control Sponsor: Consorzio Futuro in Ricerca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether a multi-domain lifestyle program—including diet, exercise, stress management, and tailored medication—can reduce chest pain and improve quality of life in people with coronary microvascular dysfunction (small vessel heart disease). About 120 patients will be randomly assigned to the lifestyle program or standard care and followed for up to 5 years. The main goal is to see if angina symptoms improve after one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multi-domain lifestyle intervention (diet, exercise, risk management, tailored medication, psychological support)
What this could lead to
If successful, this could show that a comprehensive lifestyle program improves chest pain and quality of life for people with microvascular heart disease.
What could go wrong
This is a relatively small, open-label trial (no placebo), so results may be influenced by patient expectations. The intervention is complex and may be hard to replicate in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

123 people

The number who actually took part.

Started

Oct 2023

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient admitted to hospital for chronic coronary syndrome (CCS) with indication for coronary artery angiography * absence of obstructive coronary artery disease at invasive coronary artery angiography * Coronary microvascular dysfunction as identified by invasive coronary physiology Exclusion Criteria: * Planned coronary revascularization * Co-morbidity reducing life expectancy to less than 1 year * Any factor precluding 1-year follow-up * Prior Coronary Artery Bypass Graft (CABG) surgery * Presence of a chronic total occlusion (CTO)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary microvascular disorder Microvascular Angina

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Microvascular angina Microvascular ischemia of myocardium

Contacts and locations

Locations

  • AOU Ferrara

    Ferrara, Ferrara, 44124, Italy

  • AOU di Parma

    Parma, Parma, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.